Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?

Moghissi K., Dixon K.

Source: Eur Respir J 2003; 22: 535-541
Journal Issue: September

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Moghissi K., Dixon K.. Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?. Eur Respir J 2003; 22: 535-541

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers
Source: Eur Respir J 2006; 28: 200-218
Year: 2006



Effectiveness of photodynamic therapy (PDT) in lung cancer treatment
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Photodynamic therapy (PDT) in lung cancer with disease limited to endobronchial lesions
Source: Eur Respir J 2004; 24: Suppl. 48, 699s
Year: 2004

Are biphosphonates efficient in the adjuvant treatment of lung cancer?
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006

Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers
Source: Annual Congress 2011 - PG1 Interventional pulmonology
Year: 2011



Regional laser centre experience in bronchoscopic photodynamic therapy (PDT) in inoperable bronchopulmonary cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 595s
Year: 2002

Follow-up using fluorescence bronchoscopy for the patients with photodynamic therapy treated early lung cancer
Source: Annual Congress 2012 - The broad spectrum of diagnostic bronchoscopy
Year: 2012


Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


Targeted therapy for lung cancer
Source: Eur Respir J 2015; 46: 1239-1241
Year: 2015


Preoperative endobronchial photodynamic therapy improves surgical radicalism for locally advanced NSCLC
Source: Annual Congress 2012 - From the laser through the stent to the valve: the broad spectrum of interventional pneumology
Year: 2012

Advances in target therapy for lung cancer
Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I
Year: 2014



Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Year: 2015



Multimodality lung cancer therapy – nonsurgical complications
Source: Annual Congress 2008 - High-risk patients for major lung cancer surgery
Year: 2008


New and anticipated therapeutic developments in management of non-small-cell lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013


A preliminary study on targeted therapies in advanced lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001

Radiation therapy for augmenting the efficacy of immunotherapy in advanced non-small cell lung cancer: a case-controlled study
Source: ERJ Open Res, 6 (1) 00189-2019; 10.1183/23120541.00189-2019
Year: 2020



Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019


First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology
Source: Eur Respir Rev 2014; 23: 92-105
Year: 2014